About company

Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.The company's offerings include developing a pipeline of novel, orally bioavailable, small molecule therapies to target critical intervention points in pathways of resistance to overcome treatment failure in cancer, enabling healthcare providers to discover potential treatments that offer hope to people with cancer.

US
Unknown
Not verified company